JP2017528129A5 - - Google Patents

Info

Publication number

JP2017528129A5

JP2017528129A5 JP2017510624A JP2017510624A JP2017528129A5 JP 2017528129 A5 JP2017528129 A5 JP 2017528129A5 JP 2017510624 A JP2017510624 A JP 2017510624A JP 2017510624 A JP2017510624 A JP 2017510624A JP 2017528129 A5 JP2017528129 A5 JP 2017528129A5

Authority

JP

Japan

Prior art keywords

nmi

ifp35

seq

activity

antibody

Prior art date

2015-08-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 230000000694 effects Effects 0.000 claims 20
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 18
• 239000012634 fragment Substances 0.000 claims 15
• 239000000427 antigen Substances 0.000 claims 14
• 102000036639 antigens Human genes 0.000 claims 14
• 108091007433 antigens Proteins 0.000 claims 14
• 208000035475 disorder Diseases 0.000 claims 11
• 150000001413 amino acids Chemical class 0.000 claims 8
• 201000010099 disease Diseases 0.000 claims 7
• 229920001184 polypeptide Polymers 0.000 claims 7
• 108090000765 processed proteins & peptides Proteins 0.000 claims 7
• 102000004196 processed proteins & peptides Human genes 0.000 claims 7
• 206010028980 Neoplasm Diseases 0.000 claims 6
• 239000003795 chemical substances by application Substances 0.000 claims 6
• 239000008194 pharmaceutical composition Substances 0.000 claims 6
• 108090000623 proteins and genes Proteins 0.000 claims 6
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims 5
• 239000000126 substance Substances 0.000 claims 5
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
• 238000000034 method Methods 0.000 claims 4
• 102000004169 proteins and genes Human genes 0.000 claims 4
• 125000000539 amino acid group Chemical group 0.000 claims 3
• 230000028993 immune response Effects 0.000 claims 3
• 108020005544 Antisense RNA Proteins 0.000 claims 2
• 208000023275 Autoimmune disease Diseases 0.000 claims 2
• 206010050685 Cytokine storm Diseases 0.000 claims 2
• 206010061218 Inflammation Diseases 0.000 claims 2
• 102000014150 Interferons Human genes 0.000 claims 2
• 108010050904 Interferons Proteins 0.000 claims 2
• 206010040047 Sepsis Diseases 0.000 claims 2
• 125000003275 alpha amino acid group Chemical group 0.000 claims 2
• 201000011510 cancer Diseases 0.000 claims 2
• 208000035269 cancer or benign tumor Diseases 0.000 claims 2
• 239000003184 complementary RNA Substances 0.000 claims 2
• 206010052015 cytokine release syndrome Diseases 0.000 claims 2
• 230000006806 disease prevention Effects 0.000 claims 2
• 239000003937 drug carrier Substances 0.000 claims 2
• 208000015181 infectious disease Diseases 0.000 claims 2
• 230000004054 inflammatory process Effects 0.000 claims 2
• 229940079322 interferon Drugs 0.000 claims 2
• 238000004519 manufacturing process Methods 0.000 claims 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims 2
• 108091033319 polynucleotide Proteins 0.000 claims 2
• 102000040430 polynucleotide Human genes 0.000 claims 2
• 239000002157 polynucleotide Substances 0.000 claims 2
• 230000002062 proliferating effect Effects 0.000 claims 2
• 108010001857 Cell Surface Receptors Proteins 0.000 claims 1
• 102000055056 N-Myc Proto-Oncogene Human genes 0.000 claims 1
• 108700026495 N-Myc Proto-Oncogene Proteins 0.000 claims 1
• 108020004459 Small interfering RNA Proteins 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• 230000001939 inductive effect Effects 0.000 claims 1
• 230000003993 interaction Effects 0.000 claims 1
• 102000006240 membrane receptors Human genes 0.000 claims 1
• 238000006384 oligomerization reaction Methods 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 230000028327 secretion Effects 0.000 claims 1
• 150000003384 small molecules Chemical class 0.000 claims 1
• 230000004936 stimulating effect Effects 0.000 claims 1
• 230000008685 targeting Effects 0.000 claims 1